The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 801–900 of 1,004
Tomoda, R., Seto, M., Tsumuki, H., Iida, K., Yamazaki, T., Sonoda, J., Matsumine, A., & Uchida, A. (2002) · Cancer · doi:10.1002/cncr.10793 · Cited by 51
Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFβ
Hu, B., Tack, D. C., Liu, T., Wu, Z., Ullenbruch, M. R., & Phan, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209140 · Cited by 49
“Furthermore, in normal cells that are devoid of telomerase activity, constitutive expression of TERC is detectable, confirming that it is the induction of TERT gene expression that confers telomerase activity in these cells (Feng et al., 1995; Avilion et al., 1996).”
Backgroundlontophoretic Delivery of a Telomeric Oligonucleotide
Brand, R. M., & Iversen, P. L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016092809914 · Cited by 46
Cui, W., Aslam, S., Fletcher, J. M., Wylie, D., Clinton, M., & Clark, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205981200 · Cited by 46
Telomerase reverse transcriptase subunit immunoreactivity
Iczkowski, K. A., Pantazis, C. G., McGregor, D. H., Wu, Y., & Tawfik, O. W. (2002) · Cancer · doi:10.1002/cncr.10988 · Cited by 46
“TERT, as the rate-limiting component of telomerase, is a more specific indicator of its activity compared with hTR.(20) The only in situ hybridization study of telomerase in prostate carcinoma, by Paradis et al.”
Kitagawa, Y., Kyo, S., Takakura, M., Kanaya, T., Koshida, K., Namiki, M., & Inoue, M. (2000) · PubMed · Cited by 53
A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains
Bhattacharyya, A., & Blackburn, E. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2823 · Cited by 52
Epithelial Molecular Markers in the Peripheral Blood of Patients with Colorectal Cancer
Khair, G., Monson, J. R. T., & Greenman, J. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0875-9 · Cited by 46
Implications of telomeres and telomerase in endometrial pathology
Hapangama, D. K., Kamal, A., & Saretzki, G. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw044 · Cited by 43
“The template boundary element together with the 3′ end prevents DNA synthesis beyond the template (Feng et al., 1995; Fu and Collins, 2003; Kiss et al., 2010). by guest on D ecem ber 28, 2016 http://hum upd.oxfordjournals.org/ D ow nloaded from (Ge et al., 2016).”
BackgroundInfluentialNon-canonical roles of canonical telomere binding proteins in cancers
Akıncılar, S. C., Chan, C. H. T., Ng, Q. F., Fidan, K., & Tergaonkar, V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03783-0 · Cited by 47
“The same effect was achieved when HeLa cells were treated with anti-sense TERC, which caused the cells to go into crisis state and stop proliferating from 23 to 26 cycles [86].”
BackgroundOnitake, Y., Hiyama, E., Kamei, N., Yamaoka, H., Sueda, T., & Hiyama, K. (2009) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2009.07.046 · Cited by 45
“Using a highly sensitive, PCR-based assay for measuring telomerase activity, which is known as the TRAP assay [22,23], several groups have reported telomerase activity in NBL tissues [26-30].”
BackgroundMethodGuilleret, I., Yan, P., Guillou, L., Braunschweig, R., Coindre, J.-M., & Benhattar, J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.2025 · Cited by 49
“Since most RT–PCR-based experiments showed that this RNA was widely expressed in both tumoral and non-tumoral tissues ( 9 ,10), it was concluded that hTERC was not essential to telomerase reactivation.”
BackgroundSirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation
Imanishi, T., Kobayashi, K., Kuki, S., Takahashi, C., & Akasaka, T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.031 · Cited by 48
Takeda, T., Inaba, H., Yamazaki, M., Kyo, S., Miyamoto, T., Suzuki, S., Ehara, T., Kakizawa, T., Hara, M., DeGroot, L. J., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021856 · Cited by 46
Zhao, Q., Wang, X., Yu, X., Zhai, Y.-X., He, X., Wu, S., & Shi, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2284 · Cited by 45
“Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of human telomerase (13,14), which provides the reverse transcriptase activity needed to maintain the length of the telomere (15).”
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
Nosrati, M., Li, S., Bagheri, S., Ginzinger, D. G., Blackburn, E. H., Debs, R. J., & Kashani–Sabet, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0134 · Cited by 45
“Based on the above results, and on the importance of the pseudoknot domain for telomerase activity (24) and its evolutionary conservation (23), the anti-TER 180 ribozyme was selected for additional characterization.”
BackgroundExpression of Telomerase Reverse Transcriptase (TERT) in Malignant Mesotheliomas
Kumaki, F., Kawai, T., Churg, A., Galateau-Sallé, F., Hasleton, P. S., Henderson, D. W., Roggli, V. L., Travis, W. D., Cagle, P. T., & Ferrans, V. J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200203000-00011 · Cited by 47
Eitsuka, T., Nakagawa, K., Suzuki, T., & Miyazawa, T. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.017 · Cited by 47
“In human cells the enzyme comprises three main components, hTR (human telomerase RNA component) [3], TP1 (telomerase-associated protein 1) [4], and hTERT (human telomerase reverse transcriptase) [5,6], the last of which plays a key role in telomerase activation.”
BackgroundTelomerase Activity in Human Benign Prostate Tissue and Prostatic Adenocarcinomas
Kallakury, B., Brien, T. P., Lowry, C. V., Muraca, P. J., Fisher, H. A. G., Kaufman, R. P., & Ross, J. S. (1997) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199708000-00003 · Cited by 47
Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
Bisoffi, M., Chakerian, A. E., Fore, M. L., Bryant, J. E., Hernandez, J. P., Moyzis, R. K., & Griffith, J. K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00049-5 · Cited by 45
Akiyama, M., Horiguchi‐Yamada, J., Saito, S., Hoshi, Y., Yamada, O., Mizoguchi, H., & Yamada, H. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00365-7 · Cited by 48
Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions
Mutirangura, A., Sriuranpong, V., Termrunggraunglert, W., Tresukosol, D., Lertsaguansinchai, P., Voravud, N., & Niruthisard, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.604 · Cited by 45
“DISCUSSION Telomerase is a ribonucleoprotein enzyme that synthesizes telomeres, the specialized structures containing unique simple repetitive sequences (TTAGGG in vertebrates) at the end of chromosomes (Blackburn 1991: Feng et al, 1995).”
BackgroundEffects of Size and Sequence on the lontophoretic Delivery of Oligonucleotidest
Brand, R. M., Wahl, A. O., & Iversen, P. L. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9701871 · Cited by 45
Liu, S., Nong, W., Ji, L., Zhuge, X., Wei, H., Luo, M., Zhou, L., Chen, S., Zhang, S., Lei, X., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112132 · Cited by 52
Hashimoto, Y., Murakami, Y., Uemura, K., Hayashidani, Y., Sudo, T., Ohge, H., Fukuda, E., Sueda, T., & Hiyama, E. (2007) · Surgery · doi:10.1016/j.surg.2007.07.042 · Cited by 45
Targeting the telosome: Therapeutic implications
Folini, M., Gandellini, P., & Zaffaroni, N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.014 · Cited by 46
“component (hTR) that provides the template for the de novo synthesis of telomeric DNA [8] and a catalytic subunit hTERT, which has reverse transcriptase activity [9].”
BackgroundBabizhayev, M. A., Vishnyakova, K. S., & Yegorov, Y. E. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00829.x · Cited by 53
Kim, S., Ohkuni, K., Couplan, E., & Jazwinski, S. M. (2004) · Biogerontology · doi:10.1007/s10522-004-2568-x · Cited by 52
Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells
ZHANG, R. G., ZHANG, R. P., Wang, X. W., & Xie, H. J. (2002) · Cell Research · doi:10.1038/sj.cr.7290110 · Cited by 47
Yatabe, N., Kyo, S., Kondo, S., Kanaya, T., Wang, Z., Maida, Y., Takakura, M., Nakamura, M., Tanaka, M., & Inoue, M. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700479 · Cited by 50
Drug Insight: cancer cell immortality—telomerase as a target for novel cancer gene therapies
Keith, W. N., Bilsland, A. E., Hardie, M., & Evans, T. J. (2004) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0044 · Cited by 44
The Use of Heparin for Treating Human Malignancies
Ornstein, D. L., & Zacharski, L. R. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000054112 · Cited by 43
Genes Involved in the Control of Cellular Proliferative Potentiala
Reddel, R. R. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09887.x · Cited by 44
Telomerase activity as a potential marker in preneoplastic bladder lesions
Lancelin, F., Anidjar, M., Villette, J. M., Soliman, A., Teillac, P., Duc, A. L., Fiet, J., & Cussenot, O. (2000) · British Journal of Urology · doi:10.1046/j.1464-410x.2000.00466.x · Cited by 45
Telomerase: biology and phase I trials
Kèlland, L. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00226-6 · Cited by 47
G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
Romano, F., Porzio, A. D., Iaccarino, N., Riccardi, G., Lorenzo, R. D., Laneri, S., Pagano, B., Amato, J., & Randazzo, A. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2271168 · Cited by 47
“…subunit of telomerase and it is responsible for the reverse transcriptase activity of the enzyme, while hTERC is a structural RNA that contains a templating region (5´-CUAACCCUAAC-3´) necessary for the hTERT to copy the newly synthesized telomere sequence at the terminus of the chromosome [257].”
BackgroundWaghmare, S. P., Pousinis, P., HORNBY, D. P., & Dickman, M. J. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.12.077 · Cited by 46
Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer
Saleh, S., Lam, A. K.-Y., & Ho, Y. (2007) · Pathology · doi:10.1080/00313020701716425 · Cited by 45
“This indicates that hTERT expression is the ratelimiting determinant of telomerase and could be used as means of measuring telomerase activity (10-12).”
MethodImmunotherapy updates in pancreatic cancer: are we there yet?
Gunturu, K. S., Rossi, G. R., & Wasif, M. S. (2013) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012462463 · Cited by 42
“Three components of human telomerase have been detected: human telomerase RNA component [Feng et al. 1995], human telomerase protein 1 [Nakayama et al.”
BackgroundMiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT
Li, Z., Liu, Y., Diao, H., Ma, J., & Yao, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.046 · Cited by 46
Alternative splicing is a developmental switch for hTERT expression
Penev, A., Bazley, A., Shen, M. J., Boeke, J. D., Savage, S. A., & Sfeir, A. J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.033 · Cited by 47
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
Remes, K., Norrback, K.-F., Rosenquist, R., Mehle, C., Lindh, J., & Roos, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0970 · Cited by 47
“A number of anti-telomerase treatment approaches, such as antisense oligonucleotides and reverse transcriptase inhibitors have 601 been successful in inducing telomere erosion and cell death in different permanent cell lines (Feng et al, 1995; Strahl and Blackburn, 1996).”
Telomerase deficiency promotes oxidative stress by reducing catalase activity
Pérez‐Rivero, G., Ruiz‐Torres, M. P., Díez-Marqués, M. L., Canela, A., López-Novoa, J. M., Rodríguez-Puyol, M., Blasco, M. A., & Rodríguez-Puyol, D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.017 · Cited by 49
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Li, H., Xu, D., Toh, B., & Liu, J. (2006) · Cell Research · doi:10.1038/sj.cr.7310023 · Cited by 43
Urine Telomerase: An Important Marker in the Diagnosis of Bladder Cancer
Sanchini, M. A., Bravaccini, S., Medri, L., Gunelli, R., Nanni, O., Monti, F., Baccarani, P. C., Ravaioli, A., Bercovich, E., Amadori, D., et al. (2004) · Neoplasia · doi:10.1593/neo.03433 · Cited by 46
“Telomerase consists of three subunits: an RNA component (hTR), which acts as a template for DNA replication [16]; a telomerase-associated protein (TP1) [17] of unknown function; and the telomerase reverse transcriptase (hTERT), which is responsible for catalytic activity [12,18].”
BackgroundGertler, R., Rosenberg, R., Stricker, D., Werner, M., Lassmann, S., Ulm, K., Nekarda, H., & Siewert, J. (2002) · Cancer · doi:10.1002/cncr.10939 · Cited by 43
Zhang, H., Wang, X., Wang, P., Ai, X., & Zhang, J. (2008) · Photochemical & Photobiological Sciences · doi:10.1039/b809322a · Cited by 43
Studying telomeres in a longitudinal population based study
Meyer, T. D. (2008) · Frontiers in Bioscience · doi:10.2741/2901 · Cited by 43
“2962 enzyme, consisting of a protein-RNA complex (25,28), counteracts telomere attrition, but is not or insufficiently expressed in normal somatic cells, resulting in a net TL loss in these cells (26).”
BackgroundLehner, R., Enomoto, T., McGregor, J., Shroyer, A. L., Haugen, B. R., Pugazhenthi, U., & Shroyer, K. R. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6474 · Cited by 46
Weikert, S., Krause, H., Wolff, I., Christoph, F., Schrader, M. G., Emrich, T., Miller, K., & Müller, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21168 · Cited by 49
Pendino, F., Dudognon, C., Delhommeau, F., Sahraoui, T., Flexor, M., Griscelli, A. B., Lanotte, M., & Ségal-Bendirdjian, E. (2003) · Oncogene · doi:10.1038/sj.onc.1207093 · Cited by 47
“Human telomerase is composed of at least two essential components, a template RNA component (hTR; human Telomerase RNA) and a telomerase reverse transcriptase (hTERT), which is the catalytic subunit (Feng et al., 1995; Kilian et al., 1997; Meyerson et al., 1997).”
BackgroundHills, M., Lücke, K., Chavez, E. A., Eaves, C. J., & Lansdorp, P. M. (2009) · Blood · doi:10.1182/blood-2009-01-198374 · Cited by 50
“Telomeres are maintained in the germ line by a specialized ribonucleoprotein reverse transcriptase called telomerase, which adds telomeric repeats de novo onto the 39 overhang, counteracting the attrition of telomeric repeats from incomplete endreplication.(12,13) In addition to the germ line, telomerase is present at…”
BackgroundTelomerase activity in gestational trophoblastic disease.
Cheung, A., Zhang, D. K., Liu, Y., Ngan, H., Shen, D., & Tsao, S. W. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.8.588 · Cited by 43
Hills, M., & Lansdorp, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04565.x · Cited by 40
Aravindan, N., Veeraraghavan, J., Madhusoodhanan, R., Herman, T. S., & Natarajan, M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.058 · Cited by 43
Kobayashi, R., Miyagawa, R., Yamashita, H., Morikawa, T., Okuma, K., Fukayama, M., Ohtomo, K., & Nakagawa, K. (2016) · Oncology Letters · doi:10.3892/ol.2016.5054 · Cited by 43
“TERC is a component of telomerase that extends telomeres (34).”
BackgroundLARP7 family proteins have conserved function in telomerase assembly
Collopy, L. C., Ware, T. L., Goncalves, T., í Kongsstovu, S., Yang, Q., Amelina, H., Pinder, C., Alenazi, A., Moiseeva, V., Pearson, S. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02296-4 · Cited by 42
Intracellular RNA-tracking methods
George, L., Indig, F. E., Abdelmohsen, K., & Gorospe, M. (2018) · Open Biology · doi:10.1098/rsob.180104 · Cited by 45
Henry, M. P., Hawkins, J. R., Boyle, J., & Bridger, J. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00623 · Cited by 45
“Normally, telomeres shorten as a result of each cell division, although in stem cells telomerase is active to ensure the maintenance of telomere length (Greider and Blackburn, 1989; Feng et al., 1995; Nakamura and Cech, 1998).”
BackgroundEnergetics of Quadruplex-Drug Recognition in Anticancer Therapy
Pagano, B., & Giancola, C. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662257 · Cited by 43
A trans-spliced telomerase RNA dictates telomere synthesis in Trypanosoma brucei
Sandhu, R. S., Sanford, S. L., Basu, S., Park, M., Pandya, U. M., Li, B., & Chakrabarti, K. (2013) · Cell Research · doi:10.1038/cr.2013.35 · Cited by 45
The mouse telomerase RNA 5'-end lies just upstream of the telomerase template sequence
Hinkley, C. S., Blasco, M. A., Funk, W. D., Feng, J., Villeponteau, B., Greider, C. W., & Herr, W. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.2.532 · Cited by 42
Self-citationA homogeneous time-resolved fluorescence detection of telomerase activity
Gabourdes, M., Bourgine, V., Mathis, G., Bazin, H., & Alpha‐Bazin, B. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.06.006 · Cited by 44
Peng, L., Liang, J. J., Wang, H., Song, X., Rashid, A., Gomez, H. F., Corley, L. J., Abbruzzese, J. L., Fleming, J. B., Evans, D. B., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3411 · Cited by 44
Method for Determining RNA 3' Ends and Application to Human Telomerase RNA
Zaug, A. J., Lingner, J., & Cech, T. R. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.3.532 · Cited by 42
Zhou, X.-P., Hoang, J.-M., Li, Y.-J., Seruca, R., Carneiro, F., Sobrinho-Simoes, M., Lothe, R. A., Gleeson, C. M., Russell, S. E. H., Muzeau, F., et al. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2<101::aid-gcc4>3.0.co;2-4 · Cited by 238
Sotillo, E., Sierrasesúmaga, L., & Patiño‐García, A. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000102455.36737.3c · Cited by 46
Kraveka, J. M., Li, L., Bielawski, J., Obeid, L. M., & Öğretmen, B. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.034 · Cited by 43
Quantitative analysis of hTERT mRNA expression in colorectal cancer
Niiyama, H., Mizumoto, K., Sato, N., Nagai, E., Mibu, R., Fukui, T., Kinoshita, M., & Tanaka, M. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03890.x · Cited by 45
“hTERC might function as a template for elongation of a telomere”
BackgroundDelhommeau, F., Thierry, A., Feneux, D., Lauret, E., Leclercq, E., Courtier, M. H., Sainteny, F., Vainchenker, W., & Griscelli, A. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206054 · Cited by 49
“The human telomerase reverse transcriptase (hTERT) is an RNA-dependent DNA polymerase which synthesizes telomeric DNA using the human telomerase RNA (hTR) as a template (Colgin and Reddel, 1999; Feng et al., 1995; Morin, 1989; Nugent and Lundblad, 1998).”
MethodRecent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 43
Villa, R., Porta, C. D., Folini, M., Daidone, M. G., & Zaffaroni, N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01343.x · Cited by 45
Lue, N. F., & Peng, Y. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.6.1487 · Cited by 45
Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review
Eitsuka, T., Nakagawa, K., Kato, S., Ito, J., Otoki, Y., Takasu, S., Shimizu, N., Takahashi, T., & Miyazawa, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020478 · Cited by 42
“hTR contains an RNA template complementary to the 3′ overhang of telomeres [9].”
BackgroundCRISPR/Cas9-Mediated TERT Disruption in Cancer Cells
Wen, L., Zhao, C., Song, J. W., Ma, L., Ruan, J., Xia, X., Chen, Y. E., Zhang, J., Ma, P. X., & Xu, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020653 · Cited by 46
“While TERC is constitutively expressed, TERT is suppressed in most somatic cells [6].”
BackgroundGavory, G., Farrow, M. A., & Balasubramanian, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf575 · Cited by 52
“The numbering of hTR nucleotides is based on the sequence described by Feng et al. ( 40 ).”
BackgroundMethodKrams, M., Claviez, A., Heidorn, K., Krupp, G., Parwaresch, R. M., Harms, D., & Rudolph, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63039-8 · Cited by 48
Song, J.-S., Kim, H.-P., Yoon, W., Lee, K.-W., Mee-Hye, K. I. M., Kim, K., Kim, H.-S., & Kim, Y. T. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.2344 · Cited by 45
Natural products targeting telomere maintenance
Chen, J. L.-Y., Sperry, J., Ip, N. Y., & Brimble, M. A. (2011) · MedChemComm · doi:10.1039/c0md00241k · Cited by 41
Detection of telomerase activity in oral lesions
Sumida, T., Sogawa, K., Hamakawa, H., Sugita, A., Tanioka, H., & Ueda, N. (1998) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1998.tb01925.x · Cited by 41
Compton, S. A., Elmore, L. W., Haydu, K., Jackson‐Cook, C. K., & Holt, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1452-1462.2006 · Cited by 45
“Telomerase activity requires two core components, hTERT and hTR (10, 28, 46), to be assembled into a functionally active enzyme by the Hsp90 chaperone complex (20).”
BackgroundTelomerase activity in human laryngeal squamous cell carcinomas.
Hohaus, S., Cavallo, S., Bellacosa, A., Genuardi, M., Galli, J., Cadoni, G., Almadori, G., Lauriola, L., Litwin, S., Maurizi, M., et al. (1996) · PubMed · Cited by 41
Wan, M. S., Fell, P. L., & Akhtar, S. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.309 · Cited by 43
“The RNA component, which has been cloned and se-TELOMERES are composed of the simple repetitive DNA sequenced (Feng et al., 1995), provides the template for synthe-quence TTAGGG/CCCTAA and are found at the end of sizing telomeric repeats.”
Keller, G., Brassat, U., Braig, M., Heim, D., Wege, H., & Brümmendorf, T. H. (2009) · Hematological Oncology · doi:10.1002/hon.901 · Cited by 44
Detection of circulating tumor cells in bladder cancer patients
Nezos, A., Pissimissis, N., Lembessis, P., Sourla, A., Dimopoulos, P., Dimopoulos, T., Tzelepis, K., & Koutsilieris, M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.003 · Cited by 49
Telomere shortening may be associated with human keloids
Felice, B. D., Wilson, R. R., & Nacca, M. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-110 · Cited by 40
“Telomerase is not detected in the majority of somatic cells except for in a few somatic cells such as lymphocytes and endometrium of the uterus [17].”
Chen, X., Zhang, J., Fang, Y., Zhao, C., & Zhu, Y. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.3.253 · Cited by 41
“hTERT is the human telomerase reverse transcription gene, which plays an important role in activation of telomerase (31,32).”
BackgroundBraunstein, I., Cohen‐Barak, O., Shachaf, C. M., Ravel, Y., Yalon-Hacohen, M., Mills, G. B., Tzukerman, M., & Skorecki, K. L. (2001) · PubMed · Cited by 46
Zaffaroni, N., Lualdi, S., Villa, R., Bellarosa, D., Cermele, C., Felicetti, P., Rossi, C., Orlandi, L., & Daidone, M. G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00139-9 · Cited by 41
“These include antisense-based oligonucleotide inhibitors targeting the RNA component of human telomerase (hTR) that acts as a template for the addition of new telomeric repeats by the reverse transcriptase domain of the enzyme (hTERT) [6,7].”
BackgroundTu, W., Zhang, D., Cheung, P., Tsao, S., & Lau, Y. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01272.x · Cited by 40
“One component of telomerase, the telomerase RNA component, has been cloned in mice and humans (Feng et al, 1995; Blasco et al, 1995).”
BackgroundTelomerase enzyme activation and human cell immortalization
Meyerson, M. M. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00278-1 · Cited by 42
Telomerase and c-myc expression in hepatocellular carcinomas
Liu, Y., Chen, C., Wu, H., Chan, D., Yu, J.-C., Yang, A., Cheng, Y.-L., Lee, S.-C., & Harn, H. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.01.003 · Cited by 41
Self-citationHu, B. T., & Insel, R. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1 · Cited by 42
Telomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 43
“The original antisense approach used a vector expressing antisense to the hTR RNA component stably transfected into HeLa cancer cells.(14) Fitting with the model of requiring gradual telomere erosion with each cell division, cell crisis in the antisense-treated cells occurred after 20±26 population doublings (with aro…”
BackgroundMethodInfluentialCottage, C. T., Neidig, L., Sundararaman, B., Din, S., Joyo, A. Y., Bailey, B., Gude, N., Hariharan, N., & Sussman, M. A. (2012) · STEM CELLS · doi:10.1002/stem.1211 · Cited by 40
Ding, L., Li, L., Yang, H. J., Zhou, S., Li, W., Tang, M., Shi, Y., Wei, Y., & Cao, Y. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20896 · Cited by 41
“Human telomerase ribonucleoprotein complex is composed of two major subunits contributing to enzymatic activity: an RNA subunit (hTR) and catalytic human telomerase reverse transcriptase (hTERT) subunits, and hTERT is the key determinant of the telomerase activity [Feng et al., 1995; Meyerson et al., 1997; Nakayama et…”
Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer
Adjiri, A. (2016) · Oncology and Therapy · doi:10.1007/s40487-015-0015-6 · Cited by 45
“In most organisms, the main mechanism of telomere length maintenance is assured by the telomerase consisting of a reverse transcriptase catalytic subunit (TERT) and an RNA template subunit (TERC) [51, 52].”
BackgroundDNA–dependent protein kinase in telomere maintenance and protection
Sui, J.-D., Zhang, S., & Chen, B. P. C. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-0199-0 · Cited by 41
Telomeres and Telomerase in Stem Cells during Aging and Disease
Ju, Z., & Rudolph, K. L. (2006) · KARGER eBooks · doi:10.1159/000092502 · Cited by 43
Cousins, A. R. O., Ritson, D. J., Sharma, P., Stevens, M. F. G., Moses, J. E., & Searle, M. S. (2014) · Chemical Communications · doi:10.1039/c4cc07487d · Cited by 42
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.